West Oak Capital LLC lowered its position in Clorox Co (NYSE:CLX) by 21.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,650 shares of the company’s stock after selling 450 shares during the period. West Oak Capital LLC’s holdings in Clorox were worth $222,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of CLX. Confluence Investment Management LLC increased its stake in Clorox by 10.3% in the first quarter. Confluence Investment Management LLC now owns 106,053 shares of the company’s stock worth $14,299,000 after buying an additional 9,863 shares during the last quarter. Fulton Bank N.A. bought a new stake in Clorox during the first quarter worth $219,000. Manning & Napier Advisors LLC increased its stake in Clorox by 7.1% in the first quarter. Manning & Napier Advisors LLC now owns 22,261 shares of the company’s stock worth $3,001,000 after buying an additional 1,478 shares during the last quarter. Chevy Chase Trust Holdings Inc. increased its stake in Clorox by 1.6% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 129,249 shares of the company’s stock worth $17,427,000 after buying an additional 1,990 shares during the last quarter. Finally, Park National Corp OH increased its stake in Clorox by 6.5% in the first quarter. Park National Corp OH now owns 5,440 shares of the company’s stock worth $733,000 after buying an additional 331 shares during the last quarter. 70.14% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Shares of Clorox Co (NYSE:CLX) traded down 1.00% during trading on Friday, reaching $134.29. The company had a trading volume of 811,198 shares. The company has a 50 day moving average of $136.15 and a 200-day moving average of $124.70. The firm has a market capitalization of $17.22 billion, a P/E ratio of 26.94 and a beta of 0.32. Clorox Co has a 52-week low of $111.24 and a 52-week high of $140.47.



Clorox (NYSE:CLX) last released its quarterly earnings data on Friday, February 3rd. The company reported $1.25 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.22 by $0.03. Clorox had a return on equity of 239.42% and a net margin of 11.15%. The company had revenue of $1.41 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter last year, the business posted $1.14 EPS. Clorox’s revenue for the quarter was up 4.5% on a year-over-year basis. Equities analysts expect that Clorox Co will post $5.32 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 5th. Investors of record on Wednesday, April 19th will be issued a dividend of $0.80 per share. This represents a $3.20 annualized dividend and a dividend yield of 2.38%. The ex-dividend date of this dividend is Monday, April 17th. Clorox’s dividend payout ratio (DPR) is 64.13%.

COPYRIGHT VIOLATION NOTICE: “West Oak Capital LLC Sells 450 Shares of Clorox Co (CLX)” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/04/21/west-oak-capital-llc-has-222000-position-in-clorox-co-clx-updated.html.

CLX has been the subject of a number of recent analyst reports. Zacks Investment Research raised shares of Clorox from a “hold” rating to a “buy” rating and set a $151.00 price target for the company in a research report on Wednesday, April 5th. Barclays PLC raised Clorox from an “underweight” rating to an “equal weight” rating and lowered their price target for the company from $115.00 to $111.00 in a report on Monday, January 9th. Royal Bank of Canada set a $115.00 price target on Clorox and gave the company a “hold” rating in a report on Tuesday, March 21st. B. Riley reissued a “neutral” rating and set a $125.00 price target on shares of Clorox in a report on Saturday, February 11th. Finally, Jefferies Group LLC began coverage on Clorox in a report on Tuesday. They set a “hold” rating and a $138.00 target price on the stock. Twelve equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Clorox presently has an average rating of “Hold” and a consensus price target of $128.97.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

5 Day Chart for NYSE:CLX

Receive News & Stock Ratings for Clorox Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co and related stocks with our FREE daily email newsletter.